folfirinox
Showing 1 - 25 of 46
Pancreatic Ductal Adenocarcinoma Trial (OT-101, FOLFIRINOX)
Not yet recruiting
- Pancreatic Ductal Adenocarcinoma
- OT-101
- FOLFIRINOX
- (no location specified)
Oct 5, 2023
Pancreatic Ductal Adenocarcinoma Trial in Houston (Pembrolizumab, Folfirinox)
Recruiting
- Pancreatic Ductal Adenocarcinoma
- Pembrolizumab
- Folfirinox
-
Houston, Texas
- +1 more
Dec 15, 2022
Pancreas Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in Boston (drug, radiation, procedure)
Recruiting
- Pancreas Cancer
- +2 more
- FOLFIRINOX
- +9 more
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Aug 19, 2022
Locally Advanced Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma Trial in Washington (Eryaspase,
Active, not recruiting
- Locally Advanced Pancreatic Ductal Adenocarcinoma
- Metastatic Pancreatic Ductal Adenocarcinoma
- Eryaspase
- FOLFIRINOX
-
Washington, District of ColumbiaGeorgetown Lombardi Comprehensive Cancer Center
Aug 3, 2022
Metastatic Pancreatic Cancer Trial in Philadelphia (FOLFIRINOX)
Recruiting
- Metastatic Pancreatic Cancer
- FOLFIRINOX
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Sep 26, 2022
Pancreatic Cancer Trial in United States (drug, radiation, procedure)
Active, not recruiting
- Pancreatic Cancer
- FOLFIRINOX
- +4 more
-
Aurora, Colorado
- +9 more
Sep 7, 2022
ADjuvant chemotherAPy After Curative Intent resecTion of
Recruiting
- Ampullary Adenocarcinoma
- Folfirinox
- Capox
-
Brescia, BS, ItalyFondazione Poliambulanza
Oct 3, 2023
Metastatic Pancreatic Ductal Adenocarcinoma Trial in France, Spain (CAN04, FOLFIRINOX)
Recruiting
- Metastatic Pancreatic Ductal Adenocarcinoma
- CAN04
- FOLFIRINOX
-
Bordeaux, France
- +7 more
May 16, 2022
Pancreatic Cancer Trial in Baltimore (drug, biological, radiation)
Active, not recruiting
- Pancreatic Cancer
- Cyclophosphamide
- +3 more
-
Baltimore, MarylandThe Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mar 3, 2022
Pancreatic Cancer Trial in Boston (drug, radiation, procedure)
Active, not recruiting
- Pancreatic Cancer
- FOLFIRINOX
- +3 more
-
Boston, MassachusettsMassachusetts General Hospital
May 5, 2021
Gastroesophageal Adenocarcinoma Trial in Orange (device, combination product, drug)
Not yet recruiting
- Gastroesophageal Adenocarcinoma
- ctDNA Blood Test
- +8 more
-
Orange, CaliforniaChao Family Comprehensive Cancer Center, University
Feb 8, 2023
Pancreas Cancer Trial in Cincinnati (drug, radiation, procedure)
Recruiting
- Pancreas Cancer
- Folfirinox
- +3 more
-
Tucson, Arizona
- +1 more
Sep 13, 2022
Pancreatic Cancer Trial in New York (Biopsy, FOLFIRINOX, Ciprofloxacin)
Not yet recruiting
- Pancreatic Cancer
- Biopsy
- +5 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Jul 13, 2022
Pancreas Cancer Trial in Louisville (Irreversible Electroporation (IRE), Gemcitabine, FOLFIRINOX)
Recruiting
- Pancreas Cancer
- Irreversible Electroporation (IRE)
- +2 more
-
Louisville, KentuckyUniversity of Louisville
Oct 6, 2021
Metastatic Pancreatic Cancer Trial in France (FOLFIRINOX, LV5FU2, FOLFIRI.3)
Completed
- Metastatic Pancreatic Cancer
- FOLFIRINOX
- +3 more
-
Angers, France
- +53 more
Dec 3, 2021
Colorectal Tumors Trial in São Paulo (Folfirinox)
Recruiting
- Colorectal Neoplasms
- Folfirinox
-
São Paulo, BrazilHospital Municipal Vila Santa Catarina
Oct 5, 2021
Gastric Cancer Trial in São Paulo (FOLFIRINOX)
Recruiting
- Gastric Cancer
- FOLFIRINOX
-
São Paulo, BrazilInstituto do Câncer do Estado de São Paulo
Nov 9, 2020
Urachal Cancer Trial in Seoul (FOLFIRINOX)
Recruiting
- Urachal Cancer
- FOLFIRINOX
-
Seoul, Korea, Republic ofAsan Medical Center
Oct 29, 2020
Pancreatic Adenocarcinoma Trial in Providence (FOLFIRI, FOLFIRINOX, TriSalus Infusion System)
Withdrawn
- Pancreatic Adenocarcinoma
- FOLFIRI
- +2 more
-
Providence, Rhode IslandRoger Williams Medical Center
May 27, 2021
Borderline Resectable Pancreatic Cancer Trial (FOLFIRINOX, gemcitabine + nab-paclitaxel)
Active, not recruiting
- Borderline Resectable Pancreatic Cancer
- FOLFIRINOX
- gemcitabine + nab-paclitaxel
- (no location specified)
Sep 8, 2020
Pancreatic Cancer Trial in Boston (FOLFIRINOX, Losartan, Proton Beam Radiation)
Unknown status
- Pancreatic Cancer
- FOLFIRINOX
- +2 more
-
Boston, MassachusettsMassachusetts General Hospital
Sep 7, 2020
Metastatic Pancreatic Adenocarcinoma Trial in Montpellier (GEMBRAX, FOLFIRINOX)
Completed
- Metastatic Pancreatic Adenocarcinoma
- GEMBRAX
- FOLFIRINOX
-
Montpellier, FranceInstitut regional du Cancer - Val d Aurelle
Dec 30, 2020
Locally Advanced Pancreatic Cancer, Borderline Pancreatic Inoperable Cancer, Pancreatic Cancer Trial in Birmingham (Folfirinox,
Terminated
- Locally Advanced Pancreatic Cancer
- +2 more
- Folfirinox
- Gemcitabine nab-Paclitaxel
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Aug 14, 2020
Metastatic Pancreas Cancer Trial in Amsterdam (Folfirinox)
Recruiting
- Metastatic Pancreas Cancer
- Folfirinox
-
Amsterdam, Noord-Holland, NetherlandsAcademic Medical Center
May 18, 2021